Congresswoman Tlaib notes Teva return on copay program for profit at House hearing

Michigan Congresswoman Rashida Tlaib tells Teva Pharmaceuticals CEO Kare Schultz in a line of questioning about charitable donations by drug companies at a House Oversight and Reform Committee hearing that according to his company's internal analysis the company spent 54 million dollars in commercial copay program in 2014 but in return get to a 57 million dollars back, a 371 percent profit showing that what he and other corporate negatives claimed to be charitable programs were actually profit motivated efforts to retain patients and generate sales, her constituent said the medication was needed to have a decent life without a cure for MS, social is to go back and stop misleading the public and make sure drugs improved people's right to life in jeopardy.